Supplemental material
Report
Engineering a pure and stable heterodimeric IgA for the development of multispecific therapeutics
Florian Heinkela Zymeworks Inc., Vancouver, BC, Canada
https://orcid.org/0000-0002-2383-9330View further author information
https://orcid.org/0000-0002-2383-9330View further author information, Meghan M. Verstraetea Zymeworks Inc., Vancouver, BC, CanadaCorrespondence[email protected]
https://orcid.org/0000-0003-0422-2826View further author information
https://orcid.org/0000-0003-0422-2826View further author information, , , , , , , , Martin J. Boulangerb Department of Biochemistry and Microbiology; University of Victoria, Victoria, BC, Canadahttps://orcid.org/0000-0001-6835-9309View further author information
https://orcid.org/0000-0001-6835-9309View further author information, & Eric Escobar-Cabreraa Zymeworks Inc., Vancouver, BC, Canadahttps://orcid.org/0000-0002-2749-8860View further author information
https://orcid.org/0000-0002-2749-8860View further author information show all